Fifth Third Bancorp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.9M Buy
719,424
+50,763
+8% +$6.69M 0.15% 130
2026
Q1
$93.2M Buy
668,661
+226,510
+51% +$31.7M 0.17% 118
2025
Q4
$54.3M Buy
442,151
+48,586
+12% +$5.9M 0.17% 119
2025
Q3
$43.7M Buy
393,565
+14,642
+4% +$1.66M 0.14% 130
2025
Q2
$42M Buy
378,923
+9,822
+3% +$1.05M 0.15% 129
2025
Q1
$41.4M Buy
369,101
+76,007
+26% +$7.84M 0.16% 131
2024
Q4
$27.1M Sell
293,094
-574
-0.2% -$51.7K 0.1% 157
2024
Q3
$24.6M Sell
293,668
-3,695
-1% -$282K 0.09% 162
2024
Q2
$20.4M Sell
297,363
-22,506
-7% -$1.5M 0.08% 176
2024
Q1
$23.4M Sell
319,869
-5,291
-2% -$407K 0.09% 168
2023
Q4
$26.3M Sell
325,160
-3,480
-1% -$271K 0.11% 158
2023
Q3
$24.6M Sell
328,640
-11,950
-4% -$919K 0.11% 156
2023
Q2
$26.2M Sell
340,590
-6,945
-2% -$554K 0.12% 154
2023
Q1
$28.8M Sell
347,535
-20,889
-6% -$1.73M 0.13% 147
2022
Q4
$31.6M Sell
368,424
-7,455
-2% -$590K 0.15% 145
2022
Q3
$23.2M Buy
375,879
+6,582
+2% +$415K 0.12% 158
2022
Q2
$22.8M Sell
369,297
-13,757
-4% -$852K 0.11% 168
2022
Q1
$22.8M Sell
383,054
-16,840
-4% -$1.08M 0.09% 184
2021
Q4
$29M Sell
399,894
-3,168
-0.8% -$218K 0.11% 167
2021
Q3
$28.2M Buy
403,062
+11,637
+3% +$818K 0.12% 164
2021
Q2
$27M Sell
391,425
-22,640
-5% -$1.51M 0.12% 167
2021
Q1
$26.8M Sell
414,065
-7,807
-2% -$503K 0.12% 160
2020
Q4
$24.6M Sell
421,872
-97,545
-19% -$5.89M 0.12% 156
2020
Q3
$32.8M Sell
519,417
-25,499
-5% -$1.77M 0.18% 121
2020
Q2
$41.9M Sell
544,916
-14,762
-3% -$1.13M 0.25% 100
2020
Q1
$41.8M Buy
559,678
+41,464
+8% +$2.87M 0.3% 86
2019
Q4
$33.7M Sell
518,214
-61,895
-11% -$4.03M 0.19% 115
2019
Q3
$36.8M Sell
580,109
-46,338
-7% -$3.03M 0.22% 108
2019
Q2
$42.3M Sell
626,447
-67,427
-10% -$4.44M 0.26% 102
2019
Q1
$45.1M Sell
693,874
-8,939
-1% -$594K 0.29% 96
2018
Q4
$44M Sell
702,813
-91,072
-11% -$6.37M 0.32% 85
2018
Q3
$61.3M Sell
793,885
-19,542
-2% -$1.48M 0.39% 72
2018
Q2
$57.6M Sell
813,427
-125,493
-13% -$8.86M 0.39% 70
2018
Q1
$70.8M Sell
938,920
-78,054
-8% -$6.2M 0.48% 52
2017
Q4
$72.9M Sell
1,016,974
-134,106
-12% -$10.2M 0.5% 53
2017
Q3
$93.3M Buy
1,151,080
+79,371
+7% +$6.07M 0.67% 37
2017
Q2
$75.9M Sell
1,071,709
-136,607
-11% -$9.09M 0.56% 47
2017
Q1
$82.1M Sell
1,208,316
-44,618
-4% -$3.14M 0.62% 39
2016
Q4
$89.7M Sell
1,252,934
-118,996
-9% -$8.84M 0.72% 29
2016
Q3
$109M Sell
1,371,930
-44,892
-3% -$3.65M 0.9% 20
2016
Q2
$118M Sell
1,416,822
-248,386
-15% -$22M 1% 17
2016
Q1
$153M Sell
1,665,208
-12,061
-0.7% -$1.09M 1.32% 12
2015
Q4
$170M Buy
1,677,269
+46,478
+3% +$4.84M 1.49% 9
2015
Q3
$160M Buy
1,630,791
+73,952
+5% +$8.21M 1.49% 8
2015
Q2
$182M Sell
1,556,839
-17,961
-1% -$1.96M 1.59% 6
2015
Q1
$155M Buy
1,574,800
+49,655
+3% +$5.04M 1.34% 8
2014
Q4
$144M Buy
1,525,145
+123,897
+9% +$12.8M 1.23% 8
2014
Q3
$149M Buy
1,401,248
+127,208
+10% +$12.5M 1.36% 8
2014
Q2
$106M Buy
1,274,040
+69,312
+6% +$5.4M 0.96% 16
2014
Q1
$85.4M Sell
1,204,728
-13,636
-1% -$1.07M 0.8% 24
2013
Q4
$91.5M Buy
1,218,364
+15,351
+1% +$1.07M 0.88% 19
2013
Q3
$75.6M Buy
1,203,013
+40,488
+3% +$2.42M 0.78% 31
2013
Q2
$59.6M Buy
+1,162,525
New +$60.6M 0.64% 36

Other funds holding GILD

Fifth Third Bancorp's GILD Position: Q2 2026 in Review

Fifth Third Bancorp increased its Gilead Sciences (GILD) stake by 7.6% in Q2 2026, buying an estimated $6.69M and bringing the position to 719,424 shares worth $90.9M. The position accounts for 0.15% of the portfolio, ranked #130.

Fifth Third Bancorp first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $182M in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fifth Third Bancorp held 719,424 shares of Gilead Sciences worth $90.9M as of Q2 2026.
  • Fifth Third Bancorp bought 50,763 Gilead Sciences shares in Q2 2026, an estimated $6.69M.
  • Gilead Sciences made up 0.15% of Fifth Third Bancorp's portfolio in Q2 2026, its #130 holding.
  • Fifth Third Bancorp first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Fifth Third Bancorp's Gilead Sciences position peaked at $182M in Q2 2015.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.